Spectrum Pharmaceuticals, Inc.SPPINASDAQ
Loading
Revenue ContractionContracting
Percentile Rank27
5Y CAGR-25.1%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

5Y CAGR
-25.1%/yr
Long-term compound
Percentile
P27
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$25.77M+154.8%
2022$10.11M-
2021$0.00-
2020$0.00-100.0%
2019$22.61M-79.3%
2018$109.33M-14.8%
2017$128.37M-12.3%
2016$146.44M-9.9%
2015$162.56M-13.0%
2014$186.83M-